Literature DB >> 16557658

Abatacept.

Larry Moreland1, Guy Bate, Peter Kirkpatrick.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16557658     DOI： 10.1038/nrd1989

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  62 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

2.  Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand.

Authors:  Jau-Yi Li; Hesham Tawfeek; Brahmchetna Bedi; Xiaoying Yang; Jonathan Adams; Kristy Y Gao; Majd Zayzafoon; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  [Alopecia areata].

Authors:  V von Felbert; H F Merk
Journal:  Hautarzt       Date:  2013-11       Impact factor: 0.751

4.  Abatacept.

Authors:  Eline A Dubois; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

5.  Multiscale Modeling of Complex Formation and CD80 Depletion during Immune Synapse Development.

Authors:  István P Sugár; Jayajit Das; Ciriyam Jayaprakash; Stuart C Sealfon
Journal:  Biophys J       Date:  2017-03-14       Impact factor: 4.033

6.  Digital-to-biological converter for on-demand production of biologics.

Authors:  Kent S Boles; Krishna Kannan; John Gill; Martina Felderman; Heather Gouvis; Bolyn Hubby; Kurt I Kamrud; J Craig Venter; Daniel G Gibson
Journal:  Nat Biotechnol       Date:  2017-05-29       Impact factor: 54.908

Review 7.  Vitiligo Pathogenesis and Emerging Treatments.

Authors:  Mehdi Rashighi; John E Harris
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

8.  Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.

Authors:  A Picchianti Diamanti; M M Rosado; M Scarsella; V Germano; E Giorda; S Cascioli; B Laganà; R D'Amelio; R Carsetti
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

9.  Abatacept: a new treatment option for refractory adult autoimmune enteropathy.

Authors:  Nitin K Gupta; Omer Yilmaz; Mark Fisher; Vijay Yajnik
Journal:  J Clin Gastroenterol       Date:  2014-01       Impact factor: 3.062

10.  Biologics in dermatologic therapy - an update.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.